SCHEMBL15947634

SCHEMBL15947634

CN(C)c1ccc(C#Cc2ccnc3ccccc23)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SNCA P37840 3/20 0.48
MAPT P10636 3/20 0.48
HTR2C P28335 1/20 0.46
HTR2B P41595 1/20 0.46
ACACB O00763 1/20 0.42
ADK P55263 6/20 0.41
ACVR1 Q04771 1/20 0.40
KDM1A O60341 2/20 0.39
ALDH1A1 P00352 2/20 0.39
CYP1A2 P05177 2/20 0.39
HPGD P15428 2/20 0.39
KDM4E B2RXH2 1/20 0.39
LMNA P02545 1/20 0.39
GLA P06280 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
TSHR P16473 1/20 0.39
CYP2C19 P33261 1/20 0.39
RECQL P46063 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15947635 0.85 HTR2C (0.50) MAPTHTR2CHTR2BACACBKDM1A
SCHEMBL15947637 0.83 ACACB (0.44) MAPTACACBSMN1; SMN2ADORA2A
SCHEMBL15940574 0.82 ADORA2A (0.54) MAPTACACBALDH1A1CYP1A2HPGD
SCHEMBL19449069 0.81 ATM (0.44) SNCAMAPTADKALDH1A1TSHR
SCHEMBL15947627 0.80 NCF1 (0.54) MAPTALDH1A1CYP1A2HPGDKDM4E
SCHEMBL15940638 0.80 NCF1 (0.44) MAPTACACBRECQLADORA2A
SCHEMBL15947636 0.79 HTT (0.51) ACACBACVR1KDM1AALDH1A1RECQL
SCHEMBL9185065 0.79 HTR2C (0.49) MAPTHTR2CHTR2BACVR1ALDH1A1
SCHEMBL21858037 0.77 ADORA2A (0.41) MAPTACACBALDH1A1CYP1A2HPGD
SCHEMBL17370953 0.75 CHAT (0.58) SNCAMAPTACACBADKALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9879004-B2 Substituted acetylene derivatives and their use as positive allosteric modulators of mGluR4 MERCK PATENT GMBH (DE) 2018-01-30 US disclosed
US-9879004-B2 Substituted acetylene derivatives and their use as positive allosteric modulators of mGluR4 MERCK PATENT GMBH (DE) 2018-01-30 US disclosed
US-20150376182-A1 Substituted Acetylene Derivatives and their Use as Positive Allosteric Modulators of mGluR4 MERCK PATENT GMBH (DE) 2015-12-31 US disclosed
WO-2014121883-A1 SUBSTITUTED ACETYLENE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR4 MERCK PATENT GMBH (DE) 2014-08-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150376182-A1 Substituted Acetylene Derivatives and their Use as Positive Allosteric Modulators of mGluR4 GRM4, GRIA4, GRIK4 SNCA 4051/4885MAPT 1613/4885HTR2C 280/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.